What is the address of Dr. Paulus Weerts, anesthesist?

The registered office of Dr. Paulus Weerts, anesthesist is located at Langestraat 56, 3220 Holsbeek.

Is Dr. Paulus Weerts, anesthesist still active?

Yes. According to the CBE (29 September 2026) Dr. Paulus Weerts, anesthesist is active, legal situation “Normale toestand”, started on 25 April 2005.

Is Dr. Paulus Weerts, anesthesist registered on Peppol?

Yes, Dr. Paulus Weerts, anesthesist is registered on the Peppol network with ID 0208:0873501133.

What is the enterprise number of Dr. Paulus Weerts, anesthesist?

The enterprise number of Dr. Paulus Weerts, anesthesist is BE0873501133.

When was Dr. Paulus Weerts, anesthesist founded?

Dr. Paulus Weerts, anesthesist was founded on 25 April 2005.

Who are the directors of Dr. Paulus Weerts, anesthesist?

According to the 2024 annual accounts, the directors of Dr. Paulus Weerts, anesthesist are: Paulus Weerts.

Is Dr. Paulus Weerts, anesthesist a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 April 2005; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr. Paulus Weerts, anesthesist make in 2024?

Dr. Paulus Weerts, anesthesist posted a profit after taxes of € 98,584 in financial year 2024.

What is the revenue of Dr. Paulus Weerts, anesthesist?

As a small company, Dr. Paulus Weerts, anesthesist is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 177,691.

Dr. Paulus Weerts, anesthesist (Private Limited)

Dossier Dr. Paulus Weerts, anesthesist, printed on 29 September 2026 from databakkes.be/en/0873501133/dr-paulus-weerts-anesthesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Paulus Weerts, anesthesist from Holsbeek, company number BE0873501133, closed financial year 2024 with a result of € 98,584 after tax. For that financial year Dr. Paulus Weerts, anesthesist recorded a gross margin of € 177,691 and equity of € 872,824. Compared with financial year 2023, the result moved from € 13,011 to € 98,584. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2025.

What it is worth Growing

€ 872,824

▲ 13% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 98,584

▲ € 85,572 vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 119,317

▼ 26% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 852,824.

People and assets in 2024

Vehicles and equipment

€ 11,757

▼ 56% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 11,939

Loans from banks and other lenders, long and short.

Taxes

€ 9,858

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 231,700 Gross margin 2021: € 231,700 First fiscal year in the series	€ 165,416 Gross margin 2022: € 165,416 ▼ 29% vs 2021 (€ 231,700) Unfavourable step	€ 29,807 Gross margin 2023: € 29,807 ▼ 82% vs 2022 (€ 165,416) Unfavourable step	€ 177,691 Gross margin 2024: € 177,691 ▲ € 147,884 vs 2023 (€ 29,807) Favourable step	▲ € 147,884
Profit after taxes	€ 149,097 Profit after taxes 2021: € 149,097 First fiscal year in the series	€ 93,300 Profit after taxes 2022: € 93,300 ▼ 37% vs 2021 (€ 149,097) Unfavourable step	€ 13,011 Profit after taxes 2023: € 13,011 ▼ 86% vs 2022 (€ 93,300) Unfavourable step	€ 98,584 Profit after taxes 2024: € 98,584 ▲ € 85,572 vs 2023 (€ 13,011) Favourable step	▲ € 85,572
Equity	€ 667,930 Equity 2021: € 667,930 First fiscal year in the series	€ 761,229 Equity 2022: € 761,229 ▲ 14% vs 2021 (€ 667,930) Favourable step	€ 774,241 Equity 2023: € 774,241 ▲ 2% vs 2022 (€ 761,229) Favourable step	€ 872,824 Equity 2024: € 872,824 ▲ 13% vs 2023 (€ 774,241) Favourable step	▲ 13%
Total debts	€ 59,775 Total debts 2021: € 59,775 First fiscal year in the series	€ 57,436 Total debts 2022: € 57,436 ▼ 4% vs 2021 (€ 59,775) Favourable step	€ 37,930 Total debts 2023: € 37,930 ▼ 34% vs 2022 (€ 57,436) Favourable step	€ 21,797 Total debts 2024: € 21,797 ▼ 43% vs 2023 (€ 37,930) Favourable step	▼ 43%
Cash	€ 26,249 Cash 2021: € 26,249 First fiscal year in the series	€ 982 Cash 2022: € 982 ▼ 96% vs 2021 (€ 26,249) Unfavourable step	€ 160,734 Cash 2023: € 160,734 ▲ € 159,752 vs 2022 (€ 982) Favourable step	€ 119,317 Cash 2024: € 119,317 ▼ 26% vs 2023 (€ 160,734) Unfavourable step	▼ 26%
Land & buildings	€ 331,897 Land & buildings 2021: € 331,897 First fiscal year in the series	€ 329,804 Land & buildings 2022: € 329,804 ▼ 1% vs 2021 (€ 331,897) Unchanged	€ 315,134 Land & buildings 2023: € 315,134 ▼ 4% vs 2022 (€ 329,804) Unchanged	€ 300,463 Land & buildings 2024: € 300,463 ▼ 5% vs 2023 (€ 315,134) Unchanged	▼ 5%
Retained profit	€ 647,930 Retained profit 2021: € 647,930 First fiscal year in the series	€ 741,229 Retained profit 2022: € 741,229 ▲ 14% vs 2021 (€ 647,930) Favourable step	€ 754,241 Retained profit 2023: € 754,241 ▲ 2% vs 2022 (€ 741,229) Favourable step	€ 852,824 Retained profit 2024: € 852,824 ▲ 13% vs 2023 (€ 754,241) Favourable step	▲ 13%
Dividend	€ 258,800 Dividend 2021: € 258,800 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 258,800) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 11,702 Bank debt 2021: € 11,702 First fiscal year in the series	€ 11,706 Bank debt 2022: € 11,706 Unchanged (€ 11,702) Unfavourable step	€ 11,924 Bank debt 2023: € 11,924 ▲ 2% vs 2022 (€ 11,706) Unfavourable step	€ 11,939 Bank debt 2024: € 11,939 Unchanged (€ 11,924) Unfavourable step
Balance sheet total	€ 784,204 Balance sheet total 2021: € 784,204 First fiscal year in the series	€ 845,165 Balance sheet total 2022: € 845,165 ▲ 8% vs 2021 (€ 784,204) Unchanged	€ 812,170 Balance sheet total 2023: € 812,170 ▼ 4% vs 2022 (€ 845,165) Unchanged	€ 894,621 Balance sheet total 2024: € 894,621 ▲ 10% vs 2023 (€ 812,170) Unchanged	▲ 10%

Key figures of Dr. Paulus Weerts, anesthesist, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Paulus Weerts, anesthesist?

What happened at Dr. Paulus Weerts, anesthesist in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2025 New annual accounts for financial year 2024: profit of € 98,584 (▲ € 85,572 vs 2023). Source: NBB ↗
2005 Paulus Weerts became a director. NBB
Apr 25, 2005 Start of the company according to the CBE. KBO

In short

From € 149,097 profit in 2021 to € 98,584 profit in 2024.

Paid € 162,097 in corporate taxes since 2021.

Best year ever: 2021, with € 149,097 profit.

Paid out € 258,800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Paulus Weerts, anesthesist? We notify you, reason included.

Follow Dr. Paulus Weerts, anesthesist

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Paulus Weerts

Dr. Paulus Weerts, anesthesist

Behind Dr. Paulus Weerts, anesthesist is Paulus Weerts.

See the full network in the app

Directors

According to the 2024 annual accounts

Paulus Weerts

Director

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Langestraat 56

3220 Holsbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0873.501.133
VAT number: BE 0873.501.133
Registered office: Langestraat 56, 3220 Holsbeek
Names & denominations: Dr. Paulus Weerts, anesthesist
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 April 2005
Peppol: Active · Active since 5 Oct 2025

View on CBE Public ↗ Annual accounts (NBB) ↗